Emma (Uible) Vontz
@emmavontz
Followers
93
Following
545
Media
3
Statuses
25
PhD student in @dstarczynowski's lab who thinks a lot about how NFkB is regulated in leukemic cells via @CornellCALS '18
Cincinnati, OH
Joined February 2020
Congratulations to Emma Uible (Vontz) (@emmavontz) on successfully defending her PhD thesis! Your dedication and perseverance have truly paid off — wishing you continued success and many exciting opportunities ahead!
0
2
12
Grateful for my mentor @dstarczynowski every day, but especially yesterday after my PhD defense!
Congratulations to Dr. Emma Vontz (Uible) on completing her doctoral defense today. We cannot wait to see what she does next!
0
0
2
Age-associated changes in the gut emerge as a #leukemia risk factor. Far-reaching study @Nature led by cancer experts at Cincinnati Children’s. Findings: https://t.co/FyWAZz5NlN Blog:
scienceblog.cincinnatichildrens.org
1
5
10
Super lucky to be an author on this beautiful story and a member of @dstarczynowski's incredible team!
Thrilled to share our latest research out today in @Nature: “Microbial metabolite drives ageing-related clonal hematopoiesis via ALPK1” https://t.co/xlcrZxKRU8
1
2
24
There are cathedrals everywhere for those with eyes to see 📸 IG User: JasonPhilhower. photography
19
101
1K
Had such a great summer w/ @christingodale and @Cincy_Tech! Kudos to the best advisor @dstarczynowski for letting me do this
Today was our intern, Emma U.'s , last day with CincyTech. Emma served as our inaugural Ph.D. candidate in our Life Sciences/Healthcare graduate program. She is currently pursuing her Ph.D. in Cancer and Cell Biology in the lab of Daniel Starczynowski at @CincyChildrens. (1/2)
1
1
11
Backed by CincyTech, Kurome Therapeutics takes an innovative approach to target small molecule inhibitors for the treatment of AML. Hear more about how Kurome is dedicated to developing effective cancer therapies by circumventing cancer's ability to evade traditional therapy.
1
2
3
We are excited to share our latest paper in @BloodJournal describing new functions of the IRAK1 & IRAK4 complex in MDS/AML, which has broad therapeutic implications. https://t.co/9P7ZydZ71n
13
18
110
No StarLab meeting is complete without assigning everyone’s “spirit muffins”
0
0
10
when your PI is a superstar!! @dstarczynowski
The gene TRAF6 can block progression from pre-leukemia to full-blown disease, say @CincyChildrens researchers. But research is still in the early stages and potential therapies and clinical trials may be years away. @annthompsonwvxu has more: https://t.co/Rvr3D378JW
0
0
1
If you are interested in learning about the role of IRAK1 and IRAK4 in hematologic malignancies and recent therapeutic advances in the dawning era of IRAK-targeted therapy, check out Josh Bennett's new review in Current Opinion in Hematology: https://t.co/ETyNBw16YD
2
13
55